PHASE 1/2 HIBISCUS KIDS STUDY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: SAFETY AND EFFICACY FINDINGS FROM THE COMPLETE FIRST COHORT

Authors
Category Primary study
Conference31st Congress of the European Hematology Association Congress, EHA 2026
Year 2026
This article has no abstract
Epistemonikos ID: 7b1de4692707642bdaea391e884f37de60af50c2
First added on: Aug 08, 2026